July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Neutralizing antibody titer against AAV post AAV-mediated intravitreal injection in cynomolgus monkeys.
Author Affiliations & Notes
  • Masashi Yamazaki
    Opthalmology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
    Biochemistry and Molecular Biology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Tsutomu Igarashi
    Opthalmology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
    Biochemistry and Molecular Biology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Kazuhisa Takahashi
    Opthalmology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
    Biochemistry and Molecular Biology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Koichi Miyake
    Biochemistry and Molecular Biology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Maika Kobayashi
    Opthalmology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Chiemi Yaguchi
    Opthalmology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Shuhei Kameya
    Opthalmology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Hiroshi Takahashi
    Opthalmology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Takashi Okada
    Biochemistry and Molecular Biology, Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Masashi Yamazaki, None; Tsutomu Igarashi, None; Kazuhisa Takahashi, None; Koichi Miyake, None; Maika Kobayashi, None; Chiemi Yaguchi, None; Shuhei Kameya, None; Hiroshi Takahashi, None; Takashi Okada, None
  • Footnotes
    Support  no
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4548. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Masashi Yamazaki, Tsutomu Igarashi, Kazuhisa Takahashi, Koichi Miyake, Maika Kobayashi, Chiemi Yaguchi, Shuhei Kameya, Hiroshi Takahashi, Takashi Okada; Neutralizing antibody titer against AAV post AAV-mediated intravitreal injection in cynomolgus monkeys.. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4548.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The adeno-associated virus (AAV) vector is an ideal tool for retinal gene therapy. Vitreal administration using a AAV vector has high safety without the retinal detachment. However, the transduction efficiency in the primates is extremely low. We already reported that surgical inner limiting membrane (ILM) peeling before intravitreal AAV administration acquired the strong transduction efficiency in cynomolgus monkeys. Recently, it was reported the intravitreal administration of AAV vector cause the increase of neutralizing antibody in the blood and vitreous. In this study, it was examined to compare neutralizing antibodies (NA) in the blood at pre/post AAV intravitreal administration. Moreover, we examined to whether the AAV mediated gene expression occurred in the trabecular meshwork (TM) that is responsible for draining ocular humor.

Methods : The six eyes in the three female cynomolgus monkeys were penetrated by 30-G needle into the vitreous and 50 μl of triple-mutated self-complementary AAV2 vector (1.9 × 1013 v.g./ml) encoding green fluorescent protein (GFP) was administered. NA in the serum was calculated at pre-administration, 2 weeks and 6weeks post administration. GFP expression was analyzed at 19 weeks post administration.

Results : Each NA titer is 1:10, 1:20, 1:20 (Geometric mean; 15.9) for pre-administration, 1:100, 1:300, 1:1000 (310.7) for 2 weeks post administration and 1:300, 1:1000, 1:1000 (669.4) for 6 weeks post administration. GFP expression in surgical ILM peeled retina detected, but GFP expression in TM did not detected in all eyes.

Conclusions : Up to now, it was thought that there was little influence to the whole body by intravitreal administration due to ocular immune privilege. However, once of intravitreal administration showed that NA value of a serum rises about 40 times. Interestingly, from the point of no GFP expression in TM, AAV vector might be recognized by immune system in the ocular tissue. The measurement of NA may offer a key to successful ocular gene therapy for AAV intravitreal injection.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×